Ryntexia Pharma Private Limited - Company Profile

It is a pharma private limited company based in Kanpur, Uttar Pradesh, India, established in 2018.
2018 Kanpur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Ryntexia Pharma Private Limited

Ryntexia Pharma Private Limited, a active private limited company, was established on 03 December 2018 in Kanpur, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74999UP2018PTC110816. Registered under ROC Roc Uttar Pradesh I. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Udaya Singh Tomar (Director), Neelam Singh Tomar (Director). It holds no open charges and ₹0.63 M settled loans. Its latest AGM occurred on 09 September 2025, with the balance sheet filed on 31 March 2025. It is based at Mig -173/Mig Block Tatya Tope Nagar Phase Ii, Kanpur, Uttar Pradesh, 208022.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999UP2018PTC110816

  • Registration Number

    110816

  • Incorporation Date

    03 December 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Uttar Pradesh I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 0.63 M
  • Revenue Growth **** 184.34%
  • Profit Growth **** 13.25%
  • Ebitda **** -1827.77%
  • Net Worth 17.81%
  • Total Assets **** 252.53%
Company report

Ryntexia Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Ryntexia Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ryntexia Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Udaya Singh Tomar Director 03 Dec 2018 Current
Neelam Singh Tomar Director 03 Dec 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ryntexia Pharma.

Ryntexia Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 184.34% increase. The company also saw a substantial improvement in profitability, with a 13.25% increase in profit. The company's net worth Soared by an impressive increase of 17.81%.

Ryntexia Pharma revenue growth over time
Ryntexia Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 184.34%
*******
*******
*******
*******
Revenue from Operations
*******
 180.57%
*******
*******
*******
*******
Total Assets
*******
 252.53%
*******
*******
*******
*******
Profit or Loss
*******
 13.25%
*******
*******
*******
*******
Net Worth
*******
 17.81%
*******
*******
*******
*******
EBITDA
*******
 -1827.77%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ryntexia Pharma?

In 2019, Ryntexia Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹628,000.00

Charges Breakdown by Lending Institutions
  • Indian Overseas Bank : 0.06 Cr
Latest Charge Details
Date Lender Amount Status
25 Jun 2021 Indian Overseas Bank ₹0.45 M Satisfied
14 Aug 2020 Indian Overseas Bank ₹0.03 M Satisfied
30 Jul 2019 Indian Overseas Bank ₹0.15 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Ryntexia Pharma?

Unlock and access historical data on people associated with Ryntexia Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ryntexia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ryntexia Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ryntexia Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Ryntexia Pharma Private Limited last Annual general meeting of members was held on 09 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Ryntexia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I. was recorded as a recent event.

  • Charges

    A charge registered on 25 Jun 2021 via Charge ID 100490443 with Indian Overseas Bank was fully satisfied on 17 Jan 2024. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 14 Aug 2020 via Charge ID 100375034 with Indian Overseas Bank was fully satisfied on 17 Jan 2024. was documented.

  • Charges

    The activity A charge with Indian Overseas Bank of Rs. 0.45 M registered on 25 Jun 2021 with Charge ID 100490443 was modified on 21 Nov 2022. was completed.

  • Charges

    A charge with Indian Overseas Bank amounted to Rs. 0.45 M with Charge ID 100490443 was registered on 25 Jun 2021. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ryntexia Pharma Private Limited?

The CIN of Ryntexia Pharma Private Limited is U74999UP2018PTC110816.

Where is Ryntexia Pharma Private Limited headquartered?

Ryntexia Pharma Private Limited is headquartered at Mig -173/Mig Block Tatya Tope Nagar Phase Ii, Kanpur, Uttar Pradesh, 208022.

When was Ryntexia Pharma Private Limited incorporated?

Ryntexia Pharma Private Limited was incorporated on 03 December 2018.

Who are the current directors of Ryntexia Pharma Private Limited?

The current directors of Ryntexia Pharma Private Limited are

What is the primary industry of Ryntexia Pharma Private Limited?

The primary industry of Ryntexia Pharma Private Limited is Pharma.

Is Ryntexia Pharma Private Limited a listed company?

Ryntexia Pharma Private Limited is unlisted.

What is the capital structure of Ryntexia Pharma Private Limited?

The authorized capital of Ryntexia Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available